Duke 20 patient 'run-up' study of Ipilimumab plus Nivolumab therapy for glioblastoma multiforme
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Bristol-Myers Squibb Company
Start Date
April 16, 2014
End Date
June 30, 2016
Administered By
Surgery, Surgical Sciences
Awarded By
Bristol-Myers Squibb Company
Start Date
April 16, 2014
End Date
June 30, 2016